Feb 12 (Reuters)- Kidswell Bio Corporation CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2025 Dec 31, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 5.02 3.04 (+65.3 pct) Operating 84 mln loss 137 mln Recurring loss 134 mln loss 161 mln Net loss 142 mln loss 187 mln EPS loss 2.94 yen loss 4.69 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Kidswell Bio Corporation. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T